I-124 PGN650

PGN650 · Peregrine Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for I-124 PGN650, covering 2017-07-11 to 2017-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors [EARLY_Phase 1]

See pricing